Relationship between hypercholesterolaemia, endothelial dysfunction and hypertension

Journal of Hypertension

Volumn 17, Issue 5, 1999, Pages 611-619

  Hayakawa, Hiroshi ^a   Raij, Leopoldo ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

Dahl rats; Endothelin; Endothelium; Hypercholesterolaemia; Hypertension; Nitric oxide; Oxidants; Prostaglandins; Salt sensitivity

Indexed keywords

ACETYLCHOLINE; ALPHA TOCOPHEROL; CHOLESTEROL; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; IFETROBAN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN H2; SELENIUM; SODIUM CHLORIDE; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; ENDOTHELIUM LESION; ENZYME ACTIVITY; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY BLOOD VESSEL; KIDNEY PERFUSION; LIPID OXIDATION; MALE; MESENTERIC ARTERY; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SALT INTAKE; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM;

EID: 0032979282     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917050-00004     Document Type: Article

References (42)

1. 1 Forstermann U, Mugge A, Alheid U, Haverich A, Frolich JC. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 1988; 62:185-190.
2. 2 Hirata Y, Hayakawa H, Kakoki M, Tojo A, Suzuki E, Kimura K, et al. Nitric oxide release from kidneys of hypertensive rats treated with imidapril. Hypertension 1996; 27:672-678.
3. 3 Hayakawa H, Raij L. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension 1997; 29:235-241.
4. 4 Hayakawa H, Hirata Y, Suzuki E, Sugimoto T, Matsuoka H, Kikuchi K, et al. Mechanisms for altered endothelium-dependent vasorelaxation in isolated kidneys from experimental hypertensive rats. Am J Physiol 1993; 264:H1535-H1541.
5. 5 Meraji S, Jayakody L, Senaratne MP, Thomson AB, Kappagoda T. Endothelium-dependent relaxation in aorta of BB rat. Diabetes 1987; 36:978-981.
6. 6 Raij L. Hypertension, endothelium, and cardiovascular risk factors. Am J Med 1991; 90:13S-18S.
7. 7 Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333:664-666.
8. 8 Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320:454-456.
9. 9 Gardiner SM, Kemp PA, Bennett T, Palmer RM, Moncada S. Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats. Eur J Pharmacol 1992; 213:449-451.
10. 10 Tolins JP, Raij L. Effects of amino acid infusion on renal hemodynamics. Role of endothelium-derived relaxing factor. Hypertension 1991; 17:1045-1051.
11. 11 Tolins JP, Palmer RM, Moncada S, Raij L. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 1990; 258:H655-H662.
12. 12 White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 1994; 91:1044-1048.
13. 13 Ludwig PW, Hunninghake DB, Hoidal JR. Increased leucocyte oxidative metabolism in hyperlipoproteinaemia. Lancet 1982; ii:348-350.
14. 14 Holvoet P, Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J 1994; 8:1279-1284.
15. 15 Penn MS, Chisolm GM. Oxidized lipoproteins, altered cell function and atherosclerosis. Atherosclerosis 1994; 108:S21-S29.
16. 16 Staprans I, Rapp JH, Pan XM, Hardman DA, Feingold KR. Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 1996; 16:533-538.
17. 17 Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91:2546-2551.
18. 18 Raij L, Luscher TF, Vanhoutte PM. High potassium diet augments endothelium-dependent relaxations in the Dahl rat. Hypertension 1988; 12:562-567.
19. 19 Luscher TF, Raij L, Vanhoutte PM. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 1987; 9:157-163.
20. 20 Raij L, Nagy J, Coffee K, DeMaster EG. Hypercholesterolemia promotes endothelial dysfunction in vitamin E-and selenium-deficient rats. Hypertension 1993; 22:56-61.
21. 21 McGregor D. Effect of sympathetic nerve stimulation on the vasoconstrictor response in perfused mesenteric blood vessels of the rat. J Physiol 1965; 177:21-30.
22. 22 Hayakawa H, Raij L. Nitric oxide synthase activity and renal injury in genetic hypertension. Hypertension 1998; 31:266-270.
23. 23 Tschudi MR, Mesaros S, Luscher TF, Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. Hypertension 1996; 27:32-35.
24. 24 Jaimes E, Nath KA, Raij L. Hydrogen peroxide downregulates IL-1 driven mesangial iNOS activity: implications for glomerulonephritis. Am J Physiol 1997; 272:F721-F728.
25. 25 Luscher TF, Boulanger CM, Dohi Y, Yang Z. Endothelium-derived contracting factors. Hypertension 1992, 19:117-130.
26. 26 Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscaizo J, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86:228-234.
27. 27 Gey KF, Puska P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann NY Acad Sci 1989; 570:278-262.
28. 28 Scott RF, Daoud AA, Florentin RA. Animal models in atherosclerosis. In: Wissler RF, Geer JCS (editors): The pathogenesis ot atherosclerosis. Baltimore: Williams & Wilkins Co.; 1971. pp. 120-146.
29. 29 Guyton AC, Coleman TG, Cowley AV Jr, Scheel KW, Manning RD Jr, Norman RA Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972; 52:584-594.
30. 30 Hirata Y, Hayakawa H, Suzuki E, Kimura K, Kikuchi K, Nagano T, et al. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension. Circulation 1995; 91:1229-1235.
31. 31 Carroll JF, Mizelle HL, Cockrell K, Reckelhoff JF, Clower BR, Granger JP. Cholesterol feeding does not alter renal hemodynamic response to acetylcholine and angiotensin II in rabits. Am J Physiol 1997; 272:R940-R947.
32. 32 Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager M.A. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997; 95:2617-2622.
33. 33 Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340:1430-1432.
34. 34 Mattson DL, Roman RJ, Cowley AWJ. Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension 1992; 19:766-769.
35. 35 Fenoy FJ, Ferrer P, Carbonell L, Garcia-Salom M. Role of nitric oxide on papillary blood flow and pressure natriuresis. Hypertension 1995; 25:408-414.
36. 36 Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998; 101:731-736.
37. 37 Raij L. Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy. Hypertension 1998; 31:189-193.
38. 38 Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94:1298-1303.
39. 39 Rees D, Ben-Ishay D, Moncada S. Nitric oxide and the regulation of blood pressure in the hypertension-prone and hypertension-resistant Sabra rat. Hypertension 1996; 28:367-371.
40. 40 Campese VM, Tawadrous M, Bigazzi R, Bianchi S, Mann AS, Oparil S, et al. Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension. Hypertension 1996; 28:335-340.
41. 41 Ouyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO III. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P. Circulation 1997; 95:104-110.
42. 42 Bossaller C, Habib GB, Yamamoto H, Williams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987; 79:170-174.